Page 1 | Search Results | Blood | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-4 of 4

Sort by

Sort Order Select

Journal Articles

Analysis of Avapritinib Clinical Trial Data Generates a Highly Accurate Predictive Model for Advanced Systemic Mastocytosis Versus Indolent Systemic Mastocytosis Based on Peripheral Blood Testing

Ben Lampson, Aaron Zakharyan, Shai O. Shimony, Hongliang Shi, Daniel Deangelo

Blood (2024) 144 (Supplement 1): 107.

https://doi.org/10.1182/blood-2024-210181

Published: 2024

Journal Articles

Blood-Based Proteomics for Deeper Insights into Indolent Systemic Mastocytosis: The Pioneer Trial Experience

Hussein A. Abbas, Annie Nguyen, Bofei Wang, Min Chen, Guang Yang, Ben Lampson, Rachel L. Erlich, Ivo Veletic

Blood (2024) 144 (Supplement 1): 6569.

https://doi.org/10.1182/blood-2024-205556

Published: 2024

Journal Articles

Ultra-Sensitive KIT testing Uncovers Previously Undetected KIT mutations in Patients with Indolent Systemic Mastocytosis: Results from the Pioneer Trial

Deepti H. Radia, Tsewang Tashi, Ivan Alvarez-Twose, Patrizia Bonadonna, Hanneke Oude Elberink, Sonia Cerquozzi, Tracy I. George, Guang Yang, Mark Rosenzweig, Hui-Min Lin, Ben Lampson, Rachel L. Erlich, Jason Gotlib

Blood (2024) 144 (Supplement 1): 3164.

https://doi.org/10.1182/blood-2024-207798

Published: 2024

Journal Articles

Elenestinib, an Investigational, Next Generation KIT D816V Inhibitor, Reduces Mast Cell Burden, Improves Symptoms, and Has a Favorable Safety Profile in Patients with Indolent Systemic Mastocytosis: Analysis of the Harbor Trial

Blood (2023) 142 (Supplement 1): 76.

https://doi.org/10.1182/blood-2023-188904

Published: 2023